0001193125-20-182578.txt : 20200708 0001193125-20-182578.hdr.sgml : 20200708 20200629181954 ACCESSION NUMBER: 0001193125-20-182578 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20200629 DATE AS OF CHANGE: 20200708 GROUP MEMBERS: BOXER ASSET MANAGEMENT INC. GROUP MEMBERS: JOE LEWIS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IDEAYA Biosciences, Inc. CENTRAL INDEX KEY: 0001676725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474268251 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91018 FILM NUMBER: 20998325 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-6209 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Ideaya Biosciences, Inc. DATE OF NAME CHANGE: 20160609 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Boxer Capital, LLC CENTRAL INDEX KEY: 0001465837 IRS NUMBER: 203828456 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 320 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 400-3112 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 320 CITY: SAN DIEGO STATE: CA ZIP: 92130 SC 13G 1 d917803dsc13g.htm SC 13G SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. )*

 

 

IDEAYA Bioscience, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value

(Title of Class of Securities)

45166A102

(CUSIP Number)

June 19, 2020

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

Page 2 of 8

 

CUSIP No. 45166A102

 

  1    

  Name of reporting persons.

 

  Boxer Capital, LLC

  2    

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3    

  SEC use only.

 

  4    

  Citizenship or place of organization.

 

  Delaware

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     5     

  Sole voting power.

 

  -0-

  6     

  Shared voting power.

 

  2,202,812

  7     

  Sole dispositive power.

 

  -0-

  8     

  Shared dispositive power.

 

  2,202,812

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  2,202,812

10    

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11    

  Percent of class represented by amount in row (9).

 

  7.8%*

12    

  Type of reporting person

 

  OO

 

*

Based on 28,347,539 shares of Common Stock outstanding as set forth in the Issuer’s prospectus supplement (the “Prospectus Supplement”) filed with the SEC on June 18, 2020, which includes 6,666,667 shares of Common Stock issued in a public offering of Common Stock (the “Offering”) and 1,333,333 shares of Common Stock issued in a private placement of Common Stock (the “Private Placement”).

Page 3 of 8

 

CUSIP No. 45166A102

 

  1    

  Name of reporting persons.

 

  Boxer Asset Management Inc.

  2    

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3    

  SEC use only.

 

  4    

  Citizenship or place of organization.

 

  Bahamas

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     5     

  Sole voting power.

 

  -0-

  6     

  Shared voting power.

 

  2,202,812

  7     

  Sole dispositive power.

 

  -0-

  8     

  Shared dispositive power.

 

  2,202,812

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  2,202,812

10    

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11    

  Percent of class represented by amount in row (9).

 

  7.8%*

12    

  Type of reporting person

 

  CO

 

*

Based on 28,347,539 shares of Common Stock outstanding as set forth in the Prospectus Supplement, which includes 6,666,667 shares of Common Stock issued in the Offering and 1,333,333 shares of Common Stock issued in the Private Placement.

Page 4 of 8

 

CUSIP No. 45166A102

 

  1    

  Name of reporting persons.

 

  Joe Lewis

  2    

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3    

  SEC use only.

 

  4    

  Citizenship or place of organization.

 

  United Kingdom

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     5     

  Sole voting power.

 

  -0-

  6     

  Shared voting power.

 

  2,202,812

  7     

  Sole dispositive power.

 

  -0-

  8     

  Shared dispositive power.

 

  2,202,812

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  2,202,812

10    

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11    

  Percent of class represented by amount in row (9).

 

  7.8%*

12    

  Type of reporting person

 

  IN

 

*

Based on 28,347,539 shares of Common Stock outstanding as set forth in the Prospectus Supplement, which includes 6,666,667 shares of Common Stock issued in the Offering and 1,333,333 shares of Common Stock issued in the Private Placement.

Page 5 of 8

 

Item 1(a). Name of Issuer:

IDEAYA Bioscience, Inc. (the “Issuer”)

Item 1(b). Address of Issuer’s Principal Executive Offices:

7000 Shoreline Court, Suite 350

South San Francisco, California 94080

Item 2(a). Name of Person Filing:

This Schedule 13G is jointly filed by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”) and Joe Lewis (together with Boxer Capital and Boxer Management, the “Reporting Persons”). Boxer Management is the managing member and majority owner of Boxer Capital. Joe Lewis is the sole indirect beneficial owner of and controls Boxer Management.

Item 2(b). Address of Principal Business Office, or, if none, Residence:

The principal business address of Boxer Capital is: 11682 El Camino Real, Suite 320, San Diego, CA 92130. The principal business address of Boxer Management and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.

Item 2(c). Citizenship:

Boxer Capital is a limited liability company organized under the laws of Delaware. Boxer Management is a corporation organized under the laws of the Bahamas. Joe Lewis is a citizen of the United Kingdom.

Item 2(d). Title of Class of Securities:

Common Stock, $0.0001 par value (the “Common Stock”)

Item 2(e). CUSIP Number:

45166A102

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Item 4. Ownership.

 

  (a)

Amount beneficially owned:

The Reporting Persons beneficially own 2,202,812 shares of Common Stock.

 

  (b)

Percent of class:

The number of shares of Common Stock beneficially owned by the Reporting Persons represent 7.8% of the Issuer’s outstanding Common Stock (based on 28,347,539 shares of Common Stock outstanding as set forth in the Prospectus Supplement, which includes 6,666,667 shares of Common Stock issued in the Offering and 1,333,333 shares of Common Stock issued in the Private Placement).

Page 6 of 8

 

  (c)

Number of shares as to which such person has:

 

  (i)

Sole power to vote or to direct the vote:

None of the Reporting Persons has sole power to vote or to direct the vote of any shares of Common Stock.

 

  (ii)

Shared power to vote or to direct the vote:

The Reporting Persons have shared power to vote or to direct the vote of the 2,202,812 shares of Common Stock they beneficially own.

 

  (iii)

Sole power to dispose or to direct the disposition of:

None of the Reporting Persons has sole power to dispose or to direct the disposition of any shares of Common Stock.

 

  (iv)

Shared power to dispose or to direct the disposition of:

The Reporting Persons have shared power to dispose or to direct the disposition of the 2,202,812 shares of Common Stock they beneficially own.

Item 5. Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Only Boxer Capital has the right to receive dividends and the proceeds from the sale of the shares of Common Stock held by Boxer Capital.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of Group.

Not applicable.

Item 10. Certification.

(c) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Page 7 of 8

 

Exhibits

 

  1

Joint Filing Agreement, dated June 29, 2020, among the Reporting Persons.

Page 8 of 8

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

June 29, 2020

 

BOXER CAPITAL, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Authorized Signatory
BOXER ASSET MANAGEMENT INC.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director
JOSEPH C. LEWIS

/s/ Joseph C. Lewis

Joseph C. Lewis, Individually
 EX-99.1 2 d917803dex991.htm EX-99.1 EX-99.1

Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on Schedule 13G with respect to the common stock of IDEAYA Bioscience, Inc., $0.0001 par value, is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to the Schedule 13G and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of June 29, 2020.

 

BOXER CAPITAL, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Authorized Signatory
BOXER ASSET MANAGEMENT INC.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director
JOSEPH C. LEWIS

/s/ Joseph C. Lewis

Joseph C. Lewis, Individually